Page 25 - TD-1-1

Tumor Discovery Monocytes from single-cell analysis

74. Kusmartsev S, Nefedova Y, Yoder D, et al., 2004, Antigen- the pre-metastatic niche. Nature, 438(7069): 820–827.
specific inhibition of CD8+ T cell response by immature https://doi.org/10.1038/nature04186
myeloid cells in cancer is mediated by reactive oxygen
species. J Immunol (Baltimore, Md. 1950), 172(2): 989–999. 85. Matsubara T, Kanto T, Kuroda S, et al., 2013, TIE2-expressing
monocytes as a diagnostic marker for hepatocellular
https://doi.org/10.4049/jimmunol.172.2.989
carcinoma correlates with angiogenesis. Hepatology, 57(4):
75. Bronte V, Serafini P, Mazzoni A, et al., 2003, L-arginine 1416–1425.
metabolism in myeloid cells controls T-lymphocyte https://doi.org/10.1002/hep.25965
functions. Trends Immunol, 24(6): 302–306.
86. Harney AS, Arwert EN, Entenberg D, et al., 2015, Real-time
https://doi.org/10.1016/s1471-4906(03)00132-7
imaging reveals local, transient vascular permeability, and
76. Baniyash M, 2004, TCR zeta-chain downregulation: tumor cell intravasation stimulated by TIE2hi macrophage-
Curtailing an excessive inflammatory immune response. derived VEGFA. Cancer Discov, 5(9): 932–943.
Nat Rev Immunol, 4(9): 675–687.
https://doi.org/10.1158/2159-8290.CD-15-0012
https://doi.org/10.1038/nri1434
87. Lu P, Weaver VM, Werb Z, 2012, The extracellular matrix:
77. Jakubzick CV, Randolph GJ, Henson PM, 2017, Monocyte A dynamic niche in cancer progression. J Cell Biol, 196(4):
differentiation and antigen-presenting functions. Nat Rev 395–406.
Immunol, 17(6): 349–362.
https://doi.org/10.1083/jcb.201102147
https://doi.org/10.1038/nri.2017.28
88. Naba A, Clauser KR, Hoersch S, et al., 2012, The matrisome:
78. Ma Y, Adjemian S, Mattarollo SR, et al., 2013, Anticancer In silico definition and in vivo characterization by proteomics
chemotherapy-induced intratumoral recruitment and of normal and tumor extracellular matrices. Mol Cell
differentiation of antigen-presenting cells. Immunity, 38(4): Proteomics, 11(4): M111.014647.
729–741.
https://doi.org/10.1074/mcp.M111.014647
https://doi.org/10.1038/nri.2017.28
89. Kessenbrock K, Plaks V, Werb Z, 2010, Matrix
79. Kuhn S, Yang J, Ronchese F, 2015, Monocyte-derived metalloproteinases: Regulators of the tumor
dendritic cells are essential for CD8(+) T cell activation microenvironment. Cell, 141(1): 52–67.
and antitumor responses after local immunotherapy. Front
Immunol, 6: 584. https://doi.org/10.1016/j.cell.2010.03.015
90. Mason SD, Joyce JA, 2011, Proteolytic networks in cancer.
https://doi.org/10.3389/fimmu.2015.00584
Trends Cell Biol, 21(4): 228–237.
80. Zhu C, Kros JM, Cheng C, et al., 2017, The contribution of https://doi.org/10.1016/j.tcb.2010.12.002
tumor-associated macrophages in glioma neo-angiogenesis
and implications for anti-angiogenic strategies. Neuro Oncol, 91. Afik R, Zigmond E, Vugman M, et al., 2016, Tumor
19(11): 1435–1446. macrophages are pivotal constructors of tumor collagenous
matrix. J Exp Med, 213(11): 2315–2331.
https://doi.org/10.1093/neuonc/nox081
https://doi.org/10.1084/jem.20151193
81. Chittezhath M, Dhillon MK, Lim JY, et al., 2014, Molecular
profiling reveals a tumor-promoting phenotype of 92. Madsen DH, Jürgensen HJ, Siersbæk MS, et al., 2017,
monocytes and macrophages in human cancer progression. Tumor-associated macrophages derived from circulating
Immunity, 41(5): 815–829. inflammatory monocytes degrade collagen through cellular
uptake. Cell Rep, 21(13): 3662–3671.
https://doi.org/10.1016/j.immuni.2014.09.014
https://doi.org/10.1016/j.celrep.2017.12.011
82. De Palma M, Venneri MA, Roca C, et al, 2003, Targeting
exogenous genes to tumor angiogenesis by transplantation 93. Madsen DH, Leonard D, Masedunskas A, et al., 2013, M2-like
of genetically modified hematopoietic stem cells. Nat Med, macrophages are responsible for collagen degradation
9(6): 789–795. through a mannose receptor-mediated pathway. J Cell Biol,
202(6): 951–966.
https://doi.org/10.1038/nm871
https://doi.org/10.1083/jcb.201301081
83. Shojaei F, Wu X, Malik AK, et al., 2007, Tumor refractoriness
to anti-VEGF treatment is mediated by CD11b+Gr1+ 94. Guilliams M, Ginhoux F, Jakubzick C, et al., 2014, Dendritic
myeloid cells. Nat Biotechnol, 25(8): 911–920. cells, monocytes and macrophages: A unified nomenclature
based on ontogeny. Nat Rev Immunol, 14(8): 571–578.
https://doi.org/10.1038/nbt1323
https://doi.org/10.1038/nri3712
84. Kaplan RN, Riba RD, Zacharoulis S, et al., 2005, VEGFR1-
positive haematopoietic bone marrow progenitors initiate 95. DeNardo DG, Ruffell B, 2019, Macrophages as regulators of

Volume 1 Issue 1 (2022) 16 https://doi.org/10.36922/td.v1i1.4